Wearable gadget could protect dialysis Patients' hearts and brains
NCT ID NCT06832696
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new wearable device that gently removes extra fluid between dialysis sessions. Many dialysis patients struggle with fluid buildup because standard treatments remove it too quickly, causing heart and brain damage. The device is worn at home for a few hours after dialysis. The study will check if it works, is comfortable, and can be used safely in 18 adults on dialysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
wearable residual ultrafiltration device (RUF-D)
What this could lead to
If successful, this could lead to a way for dialysis patients to safely remove extra fluid at home between sessions, potentially reducing organ damage and improving survival.
What could go wrong
This is a very early, small study (18 people) testing only if the device works and is comfortable. It may not prove any health benefits, and there are risks like infection or device malfunction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada